-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Börse FrankfurtEURISIN US4781601046-
Johnson & JohnsonBörse Börse FrankfurtISIN US4781601046EURSymbol JNJ
-
Johnson & JohnsonBörse Börse StuttgartEURSymbol JNJ
-
Johnson & JohnsonBörse Börse MünchenEURSymbol JNJ
-
Johnson & JohnsonBörse Börse BerlinEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Xetra FrankfurtEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Gettex System der Börse MünchenEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol JNJ
-
JOHNSON & JOHNSONBörse Quotrix System der Börse DüsseldorfEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Börse DüsseldorfEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Börse HamburgEURSymbol JNJ
-
USDJohnson & JohnsonBörse SGO
-
USDJohnson & JohnsonBörse BUE
-
Johnson & JohnsonBörse Bolsa de Comercio de Buenos Aires
-
Johnson & JohnsonBörse Bolsa de Comercio de Buenos Aires
-
Johnson & JohnsonBörse Bolsa de Comercio de Buenos Aires
-
Johnson & JohnsonBörse Bolsa Mexicana de Valore Mexiko-Stadt
-
Johnson & JohnsonBörse SSE
-
ISIN US4781601046
Symbol JNJ
Währung
EUR
Börse
Börse Frankfurt Zeitzone: Europe/Berlin
Marktkapitalisierung
99.567.000.000
Mitarbeiter
141.700
Zahlte zuletzt am 25.05.2021 eine Dividende von 1,06 USD . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Die Dividendenrendite
entsprach 14,66 % p. a.
beim aktuellen Kurs von 137,58 EUR +0,02%
Aktionärsstruktur der Johnson & Johnson
Portrait der Johnson & Johnson Aktie
Das Unternehmen Johnson & Johnson aus USA beschäftigt 141.700 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Drogerie & Kosmetik, Biotechnologie, Pharma tätig.
Johnson & Johnson ist in ungefähr 18 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter UBS ETF (IE) Factor MSCI USA Quality UCITS ETF (hedged to CHF) A-acc gewichtet Johnson & Johnson mit 4,34% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Johnson & Johnson Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Johnson & Johnson am höchsten gewichtet ist Insgesamt in 18 ETFs enthalten
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
1.951 News & Informationen zur Johnson & Johnson Aktie
Johnson & Johnson EPS beats by $0.19, beats on revenue (NYSE:JNJ)
Johnson & Johnson (JNJ): Q2 Non-GAAP EPS of $2.48 beats by $0.19; GAAP EPS of $2.35 beats by $0.31.Revenue of $23.31B (+27.1% Y/Y) beats by $770M.2021 Guidance: Revenue of…
Johnson & Johnson : Reports Q2 2021 Results
NEW BRUNSWICK, N.J., July 21, 2021 /PRNewswire/ — Johnson & Johnson today announced results for second-quarter. Our second-quarter results showcase Johnson & Johnson's diversified… | July 21, 2021
World Coronavirus Dispatch: Londoners want pay hike to return to office
Read more about World Coronavirus Dispatch: Londoners want pay hike to return to office on Business Standard. J&J's one-dose vaccine is less effective against the Delta variant, Airbnb suspends host who rejected couple for taking vaccine, and other pandemic-related news across the world
Drugmakers, pharmacies next targets for U.S. opioid settlements
Breaking News, Latest News and Current News from OANN.com. Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.
Drugmakers, pharmacies next targets for U.S. opioid settlements By Reuters
Drugmakers, pharmacies next targets for U.S. opioid settlements
Global shares edge up ahead of key earnings — while concerns simmer over surge in Covid cases
Concerns over surging Covid-19 cases eased as investors bet on economic stimulus packages and vaccination rollouts to fuel growth.
Global shares edge up ahead of key earnings – while concerns simmer over surge in Covid cases
Traders work on the floor of the New York Stock Exchange (NYSE) on December 07, 2018 in New York City Spencer Platt/Getty Images Global shares…
Hydrogel-based Drug Delivery System Market Size Worth $10.6 Billion By 2028: Grand View Research, Inc.
SAN FRANCISCO, July 21, 2021 /PRNewswire/ — The global hydrogel-based drug delivery system market size is anticipated to reach USD 10.6 billion b…
Hydrogel-based Drug Delivery System Market Size Worth $10.6 Billion By 2028: Grand View Research, Inc.
/PRNewswire/ — The global hydrogel-based drug delivery system market size is anticipated to reach USD 10.6 billion by 2028, according to a new report by Grand…
Stock futures point to further gains
Marketmind: A rocky road
Breaking News, Latest News and Current News from OANN.com. Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.
DHUnplugged #565: Wobble Baby
Marketmind: A rocky road By Reuters
Marketmind: A rocky road
Johnson & Johnson COVID-19 vaccine may not perform as well against Delta variant, says study
The study, which examined blood samples in a laboratory setting and has not yet been peer-reviewed, suggests that anyone who received the J&J vaccine may…
Need for diversity spurs holding co’s to cooperate, share intel on talent
Three of the world’s largest ad holding companies have set aside their rivalries, at the behest of client J&J, to compare notes on diversity and inclusion.
Tagesvorschau International
Wirtschafts- und Finanztermine am Mittwoch, den 21. Juli:
Catalent plans $100 mln expansion at vaccine plant in Italy
Catalent Inc plans a $100 million expansion of its plant in Agnani, Italy, where the contract drug manufacturer is currently filling millions of vials of…
Will Covid Will COVID Shots Drive Mutated Variants?
US drug firms agree to $1.18 billion opioid settlement in New York
The crisis has worsened during the pandemic, with more than 93,000 people dying from overdoses, often linked to opiates, in 2020
Big Rebound as Fear Subsides and Netflix Reports
Stocks Analysis by Zacks Investment Research covering: Alcoa Corp, Marvell Technology Group Ltd, CSX Corporation, Texas Instruments Incorporated. Read Zacks Investment Research's latest article on Investing.com
Dr. Vin Gupta encourages J&J vaccine recipients to get a Pfizer or Moderna booster
Dr. Vin Gupta explains why he’s encouraging patients who received the single-shot J&J Covid vaccine to get a Pfizer or Moderna booster shot.
Johnson & Johnson Vaccine Far Less Effective Against Delta Variant, Study Suggests
More than 13 million Americans have received the J&J vaccine.
Business Highlights:
___ US opioid lawsuits on verge of settlements with 4 companies NEW YORK (AP) — The three biggest U.S. drug distribution companies and the drugmaker Johnson & Johnson are on the verge of a $26 billion deal to settle lawsuits brought by state and local governments across the country over the toll of prescription opioids, lawyers suing on behalf of local governments said.
Stock futures are flat after major comeback on Wall Street, earnings continue
On Tuesday, stocks rebounded sharply from Monday's sell-off triggered by a Covid-inspired global growth scare.
New York, drug distributors reach $1.18 bln opioid settlement as national deal looms
NEW YORK — The three largest U.S. drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest…
FirstFT: Bezos successfully completes space flight
Amazon founder returns from space, Wall Street stocks bounce back and Trump ally arrested
Andrei Baciu: We will donate 100,000 Pfizer vaccines to Moldova this week
National COVID-19 Vaccination Coordination Committee (CNCAV) vicepresident Andrei Baciu declared on Tuesday that Romania would continue at individual and Europe…
Bargain Hunting Contributes To Significant Rebound On Wall Street
Stocks moved sharply higher over the course of the trading day on Tuesday, regaining ground following the sell-off seen in the previous session. The major averages all showed strong moves back to the upside but remain well off their record highs.
Louisiana, Baton Rouge to share in $26B opioid settlement as deal nears
Johnson & Johnson Taps Jones Day to Explore Talc Bankruptcy
Johnson & Johnson has engaged law firm Jones Day to advise the company as it explores placing a subsidiary in bankruptcy to help settle thousands of personal injury claims linking talcum-based baby powder to cancer, people familiar with the matter said.
Johnson & Johnson (JNJ) Option Traders Ready for Positive Earnings
A noticeable collection of put options remain in the open interest for JNJ and appear to be initiated as sell orders.
U.S. opioid lawsuits on verge of settlements with 4 companies
Full details of the settlement involving AmerisourceBergen, Cardinal Health and McKesson could come this week but it could take months to get final approval from state and local governments.
Responsible Flushing Alliance : Welcomes ANDRITZ and DUDE Products
Wipes Industry Innovators Join Board of Directors; Bolster the Industry’s Commitment to Educating Consumers on Smart Flushing Habits …
2:00PM Water Cooler 7/20/2021
~ Today's Water Cooler ~
North Carolina County Starts Offering Door-To-Door COVID-19 Vaccinations
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
US states near $26bn opioid settlement with J&J, drug distributors
Agreement would resolve thousands of lawsuits over deadly painkiller epidemic
Johnson&Johnson Q2 Earnings: Rebound from elective surgeries, cancer drugs sales
Johnson & Johnson (NYSE:JNJ) is scheduled to announce Q2 earnings results on Wednesday, July 21st, before market open.The consensus EPS Estimate is $2.29 (+37.1% Y/Y) and the…
DeepIntent fine-tunes tech to optimize ad campaigns, boost script lift
DeepIntent fine-tunes tech to optimize ad campaigns, boost script lift. From PR Week
Vaccine Makers Gain After Fox News Anchors Become Jab Supporters By Investing.com
Vaccine Makers Gain After Fox News Anchors Become Jab Supporters
U.S. States To Announce Settlement With Opioid Distributors
At least 44 U.S. states are believed to disclose a $26 billion settlement proposal involving J&J over nationwide opioid epidemic.